Compositions and methods for preparing factor Xa and derivatives
US-12398387-B2 · Aug 26, 2025 · US
This page is not indexed by search engines while we improve data quality.
Lu Genmin patents
Lu Genmin is listed as an inventor on 49 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lu Genmin |
| Total patents | 49 |
| First publication | Jan 22, 2015 |
| Latest publication | Aug 26, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
US-2025186563-A1 · Jun 12, 2025 · US
Antidotes to factor xa inhibitors
US-2025092380-A1 · Mar 20, 2025 · US
Antidotes to factor XA inhibitors
US-12195774-B2 · Jan 14, 2025 · US
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
US-2024189401-A1 · Jun 13, 2024 · US
Antidotes for factor xa inhibitors and methods of using the same
US-2024082367-A1 · Mar 14, 2024 · US
Preparation of factor xa derivatives
US-2024076642-A1 · Mar 7, 2024 · US
Preparation of factor Xa derivatives
US-11845966-B2 · Dec 19, 2023 · US
Antidotes for factor Xa inhibitors and methods of using the same
US-11839646-B2 · Dec 12, 2023 · US
Process for making recombinant antidote to factor xa inhibitor
US-2023383276-A1 · Nov 30, 2023 · US
Recent patents
Latest publications not already listed above.
Methods for testing andexanet potency
US-2023265483-A1 · Aug 24, 2023 · US
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
US-2023000957-A1 · Jan 5, 2023 · US
Compositions and methods for preparing factor xa and derivatives
US-2022251534-A1 · Aug 11, 2022 · US
Process for making recombinant antidote to factor xa inhibitor
US-2022098565-A1 · Mar 31, 2022 · US
Inhibition of tissue factor pathway inhibitor with factor xa derivatives
US-2021379163-A1 · Dec 9, 2021 · US
Antidotes to factor xa inhibitors
US-2021371842-A1 · Dec 2, 2021 · US
Preparation of factor xa derivatives
US-2021348149-A1 · Nov 11, 2021 · US
Antidotes for factor xa inhibitors and methods of using the same
US-2021340515-A1 · Nov 4, 2021 · US
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
US-2021085762-A1 · Mar 25, 2021 · US
Preparation of factor Xa derivatives
US-10954504-B2 · Mar 23, 2021 · US
Antidotes for factor Xa inhibitors and methods of using the same
US-10954503-B2 · Mar 23, 2021 · US
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
US-10765726-B2 · Sep 8, 2020 · US
Antidotes for factor xa inhibitors and methods of using the same
US-2020276280-A1 · Sep 3, 2020 · US
Preparation of factor xa derivatives
US-2020208131-A1 · Jul 2, 2020 · US
Antidotes for factor Xa inhibitors and methods of using the same
US-10675335-B2 · Jun 9, 2020 · US
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
US-2020129597-A1 · Apr 30, 2020 · US
Preparation of factor Xa derivatives
US-10604748-B2 · Mar 31, 2020 · US
Antidotes for factor xa inhibitors and methods of using the same
US-2019309279-A1 · Oct 10, 2019 · US
Process for making recombinant antidote to factor xa inhibitor
US-2019127720-A1 · May 2, 2019 · US
Antidotes for factor Xa inhibitors and methods of using the same
US-10190111-B2 · Jan 29, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Portola Pharm Inc | 29 |
| Alexion Pharma Inc | 20 |
| Sinha Uma | 2 |
| Lu Genmin | 2 |
| Hutchaleelaha Athiwat | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N9/6432 | 48 |
| A61P7/04 | 40 |
| C12Y304/21006 | 38 |
| A61K38/4846 | 37 |
| A61P7/02 | 27 |